跳至主要内容
临床试验/NCT05581134
NCT05581134招募中不适用

Effectiveness of Immersive Virtual Reality Rehabilitation Program to Reduce Symptoms Severity and Improve Quality of Life in Patients With Functional Motor Disorders

Marialuisa Gandolfi2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2022年9月29日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
36
试验地点
2
主要终点
Change in the Simplified Functional Movement Disorders Rating Scale (S-FMDRS) score

研究概览

简要总结

The study aims to demonstrate the effectiveness and superiority of a 5-day immersive VR-rehabilitation treatment versus a 5-day conventional rehabilitation treatment in reducing FMDs symptoms severity, assessed by the Simplified Functional Movement Disorders Rating Scale (S- FMDRS).

详细描述

This is a single-blind, randomized controlled trial to evaluate the superiority of immersive VR distractors combined with graded physical exercises over conventional rehabilitation (without any VR distractors) to reduce FMDs symptoms and improve gait and balance. Patients will be randomized to receive the experimental training (VRG) or the control training (CRG) (allocation ratio 1:1). The primary and secondary outcomes will be measured by the same examiner before (T0), at the end of the treatment (T1), and at three-month follow-up after the end of the treatment (T2). The test order will be the same across all evaluation sessions. The examiner will be blinded to group assignments.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

An examiner blinded to group allocation will assess all patients. To keep blindness, the examiner will not ask for information about the treatment to the patients or the caregivers, and this last will be instructed not to give any extra information outside of the examiner's questions.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • were: established diagnosis of FMDs, age ≥ 18 years, and acceptance of the diagnosis.

排除标准

  • were: prominent dissociative seizures, prominent cognitive and/or physical impairment that precluded signing the informed consent form for study participation based on clinical judgment, incomplete assessment, and questionnaire because of language comprehension difficulties.

结局指标

主要结局

Change in the Simplified Functional Movement Disorders Rating Scale (S-FMDRS) score

时间窗: Before the intensive 5-day rehabilitation program (T0), after the intensive 5-day rehabilitation program (T1), and after 12 weeks (T2).

Objective-rated validated scale to rate the duration and severity of functional motor symptoms (range: 0-54; higher = worse).

次要结局

  • Change in the Multidimensional Fatigue Inventory Scale (MFI-20) score(Before the intensive 5-day rehabilitation program (T0), after the intensive 5-day rehabilitation program (T1), and after 12 weeks (T2).)
  • Change in sway area (mm2)(Before the intensive 5-day rehabilitation program (T0), after the intensive 5-day rehabilitation program (T1), and after 12 weeks (T2).)
  • Change in the Beck Depression Inventory (BDI-II) score(Before the intensive 5-day rehabilitation program (T0) and after 12 weeks (T2).)
  • Change in the Clinical Global Impression (CGI) score(Before the intensive 5-day rehabilitation program (T0) and after 12 weeks (T2).)
  • Change in Swing time (%)(Before the intensive 5-day rehabilitation program (T0), after the intensive 5-day rehabilitation program (T1), and after 12 weeks (T2).)
  • Change in Stride length (cm)(Before the intensive 5-day rehabilitation program (T0), after the intensive 5-day rehabilitation program (T1), and after 12 weeks (T2).)
  • Change in the Brief Pain Inventory (BPI) score(Before the intensive 5-day rehabilitation program (T0), after the intensive 5-day rehabilitation program (T1), and after 12 weeks (T2).)
  • Change in gait speed (cm/sec)(Before the intensive 5-day rehabilitation program (T0), after the intensive 5-day rehabilitation program (T1), and after 12 weeks (T2).)
  • Change in total excursion path (mm)(Before the intensive 5-day rehabilitation program (T0), after the intensive 5-day rehabilitation program (T1), and after 12 weeks (T2).)
  • Change in the Beck Anxiety Inventory (BAI) score(Before the intensive 5-day rehabilitation program (T0) and after 12 weeks (T2).)
  • Change in the 12-item Short-Form Health Survey (SF-12) score(Before the intensive 5-day rehabilitation program (T0) and after 12 weeks (T2).)
  • Change in velocity of Cop displacement in the anteroposterior directions (mm/s)(Before the intensive 5-day rehabilitation program (T0), after the intensive 5-day rehabilitation program (T1), and after 12 weeks (T2).)
  • Change in Stride time (s)(Before the intensive 5-day rehabilitation program (T0), after the intensive 5-day rehabilitation program (T1), and after 12 weeks (T2).)
  • Change in velocity of Cop displacement in the mediolateral directions (mm/s)(Before the intensive 5-day rehabilitation program (T0), after the intensive 5-day rehabilitation program (T1), and after 12 weeks (T2).)
  • Change in the Toronto Alexithymia Scale (TAS-20) score(Before the intensive 5-day rehabilitation program (T0) and after 12 weeks (T2).)

研究者

发起方
Marialuisa Gandolfi
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Marialuisa Gandolfi

MD, PhD

Universita di Verona

研究点 (2)

Loading locations...

相似试验